CD274 and neoplasm: PD-L1 is present on the surface of tumor cells and, when bound to PD-1 receptors on T cells, it acts as a “second signal” (the first being antigen expressed on major histocompatibility complex (MHC) binding to T-cell receptor (TCR)) to suppress the activation of T cells.